|
Papers and Abstracts
McCoy, J.L., Herberman, R.B., Head, J.F., and Elliott, R.L.: Predicting Survival in Breast Cancer Patients by Measuring Cellular Immunity Against Tumor Associated Antigens. Breast Cancer Res. Treat. 16:69, 1990.
Head, J.F., Elliott, R.L., and McCoy, J.L.: Evaluation of Lymphocyte Immunity in Breast Cancer Patients. Breast Cancer Res. Treat. 26:77-88, 1993.
Head, J.F., Wang, F., Elliott, R.L., and McCoy, J.L.: Assessment of Immunological Competence and Host Reactivity Against Tumor Antigens in Breast Cancer Patients: Prognostic Value and Rationale of Immunotherapy Development. Ann. New York Acad. Sci. 690:340-342, 1993.
Elliott, R.L., Head, J.F., and McCoy, J.L.: Immunomodulation of Lymphocyte-mediated Immunity in Breast Cancer Patients Following Adjuvant Chemotherapy. Proc. Amer. Assoc. Soc. Clin. Oncol. 12:294, 1993.
Head, J.F., Elliott, R.L., and McCoy, J.L.: Effect of Adjuvant Chemotherapy on Lymphocyte-mediated Immunity in Breast Cancer Patients. J.Immunother. 14:365, 1993.
Elliott, R.L., Head, J.F., and McCoy, J.L.: Comparison of Estrogen and Progesterone Receptor Status to Lymphocyte Immunity Against Tumor Antigens in Breast Cancer Patients. Breast Cancer Res. Treat. 30:299-304, 1994.
Elliott, R.L., Head, J.F., and McCoy, J.L.: Relationship of Serum and Tumor Levels of Iron and Iron-binding Proteins to Lymphocyte Immunity Against Tumor Antigen in Breast Cancer Patients. Breast Cancer Res. Treat. 30:305-309, 1994.
Head, J.F., Wang, F., and Elliott, R.L.: Lymphocyte Blastogenesis Assay (LBA) Monitoring of Breast Cancer Patients (PTs) Vaccinated with Autologous and Allogeneic Tumor-associated Antigens. Proc. Amer. Soc. Clin. Oncol. 13:301, 1994.
Head, J.F., Wang, F., and Elliott, R.L.: Lymphocyte Blastogenesis Assay Monitoring of Changes in the Immune Status of Breast Cancer Patients Vaccinated with Autologous and Allogeneic Tumor-Associated Antigens. Breast Cancer Res. Treat. 32:62, 1994.
Head, J.F., Wang, F., Hailey, M.W., and Elliott, R.L.: Vaccination of Breast Cancer Patients with Autologous Tumor-Associated Antigens Results in Increased Lymphocyte Blastogenesis Assay Ratios and Decreased Serum Concentrations of the Tumor Marker 15-3. Southeastern Surg. Conference 63:9, 1995.
Head, J.F., Wang, F., and Elliott, R.L.: Vaccination of Breast Cancer Patients with Autologous Tumor-associated Antigens Results in Decreased Serum Concentrations of the Tumor Marker CA 15-3. Journal Tumor Marker Oncol. 10:45, 1995
Jiang, X.P., Head, J.F., Yang, D.C., and Elliott, R.L.: Vaccination of Breast Cancer Patients With Autologous Tumor-associated Antigens Results in Reduction of Serum Interleukin-6. Proc. Amer. Assoc. Cancer Res. 39:2841, 1998.
Jiang, X.P., Head, J.F., and Elliott, R.L.: Vaccination of Breast Cancer Patients with Autologous Tumor-associated Antigens Results in Reduction of Serum Interleukin-6. Proc. Soc. Surg. Oncol. 52:39, 1998.
Jiang, X.P., Yang, D.C., Elliott, R.L., and Head, J.F.: Serum IL-6 Concentration is Increased in Postmenopausal and Estrogen Receptor Negative Breast Cancer Patients. Breast Cancer Res. Treat. 50:480, 1998.
Jiang, X.P., Yang, D.C., Head, J.F., and Elliott, R.L.: All-trans-retinoic Acid Down-Regulates Interleukin-6 Synthesis in Human Breast Cancer Cells. Proc. Amer. Assoc. Cancer Res. 40:417, 1999.
Head, J.F., Jiang, X.P., Yang, D.C., and Elliott, R.L.: Serum Interleukin (IL-6) Concentration Correlates with Serum Tumor Marker CA15-3 Concentration in Breast Cancer Patients. Proc. Amer. Soc. Clin. Oncol. 18:2436, 1999.
Jiang, X.P., Yang, D.C., Elliott, R.L., Head, J.F.: Serum IL-6 Reduction After Vaccination of Breast Cancer Patients with Tumor-associated Antigens is Related to Estrogen Receptor Status. J. Immunother. 22:459, 1999.
Jiang, X.P., Yang, D.C., Elliott, R.L., and Head, J.F.: Interleukin-6 Enhances Tumor Antigen Expression in the MCF-7 Human Breast Cancer Cell Line and Breast Cancer Patients. Breast Cancer Res. Treat. 57:374, 1999.
Jiang, X.P., Yang, D.C., Head, J.F., and Elliott, R.L.: Interleukin-6 is a Growth Factor for Human Breast Cancer Cells. Breast Cancer Res. Treat. 57:477, 1999.
Jiang, X.P., Yang, D.C., Elliott, R.L., and Head, J.F.: Immune Responses in Breast Cancer Patients Vaccinated with Autologous Tumor Cells, Allogeneic Tumor Cells and the Tumor Antigen CA15-3. Cancer Biother. Radiopharm. 15:110, 2000.
Jiang, X.P., Yang, C.C., Elliott, R.L., and Head, J.F.: Reduction in Serum IL-6 After Vaccination of Breast Cancer Patients with Tumor-associated Antigens is Related to Estrogen Receptor Status. Cytokine 12:458-465, 2000.
Jiang, X.P., Yang, D.C., Elliott, R.L., and Head, J.F.: Vaccination with a Mixed Vaccine of Autogenous and Allogeneic Breast Cancer Cells and Tumor Associated Antigens CA15-3, CEA and CA125 - Results in Immune and Clinical Responses in Breast Cancer Patients. Cancer Biother. Radiopharm. 15:495-505, 2000.
Jiang, X.P., Head, J.F., Yang, D.C., and Elliott, R.L.: Immune Responses in Breast Cancer Patients Vaccinated with Autologous and Allogeneic Tumor Cells. Eur. J. Sur. Oncol. 26:260, 2000.
Jiang, X.P., Yang, D.C., Elliott, R.L., and Head, J.F.: Vaccination with a Mixture of Autologous and Allogeneic Breast Cancer Cells and the Tumor Associated Antigen CA15-3, CEA, and CA125: Results in Immune and Clinical Responses in Breast Cancer Patients. Proc. Amer. Soc. Clin. Oncol. 19:1827, 2000.
Elliott, R.L., Suits, J.A. and Head, J.F.: Combination Chemotherapy and Active immunotherapy for Breast Cancer Patients with Advanced Disease. Southeastern Surg. Conference 69: 12, 2001.
Hsu, K., Head, J.F., Jiang, X., and Elliott, R.L.: Whole Cell Preparations of MCF-7 Breast Carcinoma Cells are More Active Than Lysed Cell Preparations in Lymphocyte Blastogenesis Assays (LBAs) of Breast Cancer Patients. Proc. Amer. Soc. Clin. Oncol. 23:2596, 2004.
Head, J.F., Hsu, K., Jiang, X., and Elliott, R.L.: Multiple Antigens in a Breast Cancer Vaccine Result in a Higher Immune Response Rate in Breast Cancer Patients. Proc. Amer. Soc. Clin. Oncol. 23:2607, 2004.
Elliott, R.L., and Head, J.F.: Autologous Vaccine Improves Host Immunity in Breast Cancer. Proc. Am. Soc. Breast Surg. 5:34, 2004.
Elliott, R.L., and Head, J.F.: Improving Host Immunity in Breast Cancer with an Autologous Vaccine. Cancer Immunotherapeutics (CHI) 1:5, 2004.
Head, J.F., and Elliott, R.L.: Phase I/II Clinical Trials of Breast and Prostate Cancer Vaccines Consisting of Biological Adjuvants and Cellular and Protein Antigens. Breast and Prostate Cancer “Similarities and Differences” for Pathologists and Clinicians 1:2, 2005
Elliott, R.L., and Head, J.F.: Autologous Vaccine Improves Host Immunity in Breast Cancer Patients. Am. Soc. Breast Disease 29:46, 2005.
Elliott, R.L., and Head, J.F.: Host Immunity Ignored in Clinical Oncology: A Medical Opinion. Cancer Biother. Radiopharm. 20:119-121, 2005.
Patent
Vaccination of Cancer Patients Using Tumor-associated Antigens Mixed with Interleukin-2 and Granulocyte-macrophage Colony Stimulating Factor. Jonathan F. Head and Robert L. Elliott, 1995.
|
